Keros TherapeuticsKROS
那斯達克 · USD
14.32
0.00
(0.00%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Keros TherapeuticsKROS
14.32
0.00
(0.00%)
財務數據
損益表
- -
- -
- -
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.03
- 2.11
- -
- -
- -
- -
- 1687.50
- -41.96
- -55.42
- 948.65
- 684.02
- 6844.31
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 211,246 | 3,042 | 388 | 37 | 83 | 143 | 8 | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 211,246 | 3,042 | 388 | 37 | 83 | 143 | 8 | - | - | - |
營業費用 | 59,206 | 56,296 | 59,045 | 50,476 | 48,566 | 46,598 | 43,288 | 41,337 | 38,869 | 31,960 |
研發費用 | 48,709 | 45,631 | 49,225 | 40,515 | 38,258 | 37,493 | 34,140 | 32,534 | 31,091 | 24,867 |
推銷及管理費用 | 10,497 | 10,665 | 9,820 | 9,961 | 10,308 | 9,105 | 9,148 | 8,803 | 7,778 | 7,093 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 152,040 | -53,254 | -58,657 | -50,439 | -48,483 | -46,455 | -43,280 | -41,337 | -38,869 | -31,960 |
其他收入及費用 | 6,454 | 7,528 | 5,701 | 5,182 | 5,369 | 6,212 | 3,840 | 3,832 | 3,065 | 2,242 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 158,494 | -45,726 | -52,956 | -45,257 | -43,114 | -40,243 | -39,440 | -37,505 | -35,804 | -29,718 |
所得稅 | 10,043 | 300 | - | - | - | - | - | - | - | - |
稅後純益 | 148,451 | -46,026 | -52,956 | -45,257 | -43,114 | -40,243 | -39,440 | -37,505 | -35,804 | -29,718 |
基本每股稅後盈餘(元) | 3.66 | -1.14 | -1.41 | -1.25 | -1.21 | - | -1.33 | -1.27 | -1.26 | -1.09 |
稀釋每股稅後盈餘(元) | 3.62 | -1.12 | -1.42 | -1.25 | -1.21 | -1.34 | -1.33 | -1.27 | -1.26 | -1.10 |
基本平均股數(千股) | 40559.00 | 40337.00 | 37590.00 | 36103.00 | 35685.00 | - | 29668.00 | 29602.00 | 28369.00 | 27326.00 |
稀釋平均股數(千股) | 41021.00 | 40337.00 | 37590.00 | 36103.00 | 35685.00 | - | 29668.00 | 29602.00 | 28369.00 | 27326.00 |
還原基本每股稅後盈餘(元) | 3.66 | -1.14 | -1.41 | -1.25 | -1.21 | - | -1.33 | -1.27 | -1.26 | -1.09 |
還原稀釋每股稅後盈餘(元) | 3.62 | -1.12 | -1.42 | -1.25 | -1.21 | -1.34 | -1.33 | -1.27 | -1.26 | -1.10 |
還原基本平均股數(千股) | 40,559 | 40,337 | 37,590 | 36,103 | 35,685 | - | 29,668 | 29,602 | 28,369 | 27,326 |
還原稀釋平均股數(千股) | 41,021 | 40,337 | 37,590 | 36,103 | 35,685 | - | 29,668 | 29,602 | 28,369 | 27,326 |
EBITDA(千元) | 158,838 | -45,394 | -52,642 | -44,951 | -42,837 | -39,996 | -39,230 | -37,314 | -35,637 | -29,591 |